Commentary on: Randomized Split-Face Study to Assess the Efficacy and Safety of AbobotulinumtoxinA Versus OnabotulinumtoxinA in the Treatment of Melomental Folds (Depressor Anguli Oris)

Dermatol Surg. 2015 Nov;41(11):1326-7. doi: 10.1097/DSS.0000000000000462.

Author

Shannon Humphrey¹

Affiliation

¹ Clinical Assistant Professor, Director of Continuing Medical Education, University of British Columbia, Department of Dermatology & Skin Science Vancouver, Canada.

PMID: 26509944
DOI: 10.1097/DSS.0000000000000462

No abstract available

Publication types

Letter
Comment

MeSH terms

Botulinum Toxins, Type A / therapeutic use*
Facial Expression*
Facial Muscles / drug effects*
Female
Humans
Neuromuscular Agents / therapeutic use*

Substances

Neuromuscular Agents
Botulinum Toxins, Type A
incobotulinumtoxinA